Liu Yining, Wang Sisi, Yang Fan, Wang Xuepeng, Zhang Jierui, Han Xinkun, Zhang Xipeng, Wang Zhiguo
The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
Front Chem. 2024 May 1;12:1389399. doi: 10.3389/fchem.2024.1389399. eCollection 2024.
Pathological scars (PS), including hypertrophic scars (HTS) and keloids, are a common complication of poor wound healing that significantly affects patients' quality of life. Currently, there are several treatment options for PS, including surgery, drug therapy, radiation therapy, and biological therapy. However, these treatments still face major challenges such as low efficacy, high side effects, and a high risk of recurrence. Therefore, the search for safer and more effective treatments is particularly urgent. New materials often have less immune rejection, good histocompatibility, and can reduce secondary damage during treatment. New technology can also reduce the side effects of traditional treatments and the recurrence rate after treatment. Furthermore, derivative products of new materials and biomaterials can improve the therapeutic effect of new technologies on PS. Therefore, new technologies and innovative materials are considered better options for enhancing PS. This review concentrates on the use of two emerging technologies, microneedle (MN) and photodynamic therapy (PDT), and two novel materials, photosensitizers and exosomes (Exos), in the treatment of PS.
病理性瘢痕(PS),包括增生性瘢痕(HTS)和瘢痕疙瘩,是伤口愈合不良的常见并发症,严重影响患者的生活质量。目前,PS有多种治疗选择,包括手术、药物治疗、放射治疗和生物治疗。然而,这些治疗仍面临着诸如疗效低、副作用大以及复发风险高等重大挑战。因此,寻找更安全、更有效的治疗方法尤为迫切。新材料通常具有较低的免疫排斥反应、良好的组织相容性,并且可以减少治疗过程中的二次损伤。新技术还可以降低传统治疗的副作用和治疗后的复发率。此外,新材料和生物材料的衍生产品可以提高新技术对PS的治疗效果。因此,新技术和创新材料被认为是改善PS的更好选择。本综述重点介绍了两种新兴技术——微针(MN)和光动力疗法(PDT),以及两种新型材料——光敏剂和外泌体(Exos)在PS治疗中的应用。